Human Products
Bring Technology to Your life
iFinDx COVID-19 IgM/IgG
Chromatographic immunoassay kit for the rapid and differential detection of immunoglobulin M (lgM) and immunoglobulin G (IgG) against SARS-CoV-2 using serum, plasma and whole blood from human.
- Product features
-
- MFDS approval
- CE mark
- Getting results In 20 minutes
- Simple and easy to use
- Optimized for Point of Care with a small diagnostic kit
- No need to use extra reader
- High diagnostic accuracy
- Economical and capable of mass testing
Specification
Specimen Serum, Plasma, Whole blood Specimen volume Serum, Plasma 10㎕ Whole blood 20㎕ Test time 15 ~20 minutes Storage temperature 2-30℃ Expiration date Refer to label for expiration date The COVID-19 disease caused by SARS-CoV-2 is a new respiratory epidemic and was declared "pandemic" by the World Health Organization (WHO), the World Health Organization, in March 2020. Symptoms of this epidemic vary, but are mainly fatigue, high fever, cough, and in more severe cases, breathing problems and severe lung damage. Although molecular diagnostics are the standard diagnostic method for COVID-19, rapid antigen testing, which is simple, convenient, and ready to be tested in the field, has been widely used in quarantine in most developed countries, including the United States, Japan, and Europe, due to various constraints (dependence on accuracy by gene extraction technology, longer than six hours of analysis, expensive analytical equipment, and highly trained professionals). GenBody COVID-19 Ag (GenBody COVID-19 Ag) product is a rapid immunoassay method that diagnoses the antigen of the SARS COVID 2 virus that causes COVID-19 disease in a qualitative way using samples collected using cotton swabs from human nasopharynx and nasopharynx.
